EASL Campus
Access world-leading education, research, and guidelines from EASL
Latest Updates
Stay up to date with the latest content and events in hepatology
Advanced HCC Treatment Strategies
Expert insights on the latest hepatocellular carcinoma treatment approaches and clinical outcomes.
EASL Clinical Practice Guidelines: NASH Management 2024
Updated guidelines for the diagnosis and management of non-alcoholic steatohepatitis.
Top-Rated Sessions from EASL Congress 2024
Curated collection of the highest-rated presentations from this year's congress.
Clinical Practice Guidelines
Access the latest evidence-based guidelines for hepatology practice
Clinical Practice Guidelines: MASLD Management
Comprehensive guidelines for metabolic dysfunction-associated steatotic liver disease diagnosis and management.
Clinical Practice Guidelines: HCC Surveillance
Updated recommendations for hepatocellular carcinoma screening and surveillance protocols.
Articles in Press
Latest research publications from JHEP and JHEP Reports
Artificial intelligence-based prediction of hepatocellular carcinoma recurrence after liver transplantation: A machine learning approach
Maria Rodriguez-Santos, James Chen, Elena Kowalski, Robert Thompson
Available online June 20, 2024
Long-term outcomes of direct-acting antivirals in hepatitis C patients with decompensated cirrhosis: A retrospective study
Prof. Andrea Bianchi, Dr. Sarah Mitchell, Prof. Klaus
Available online June 20, 2024
Supporters
EASL Campus is supported by Gilead, GSK, Novo Nordisk, Madrigal Pharmaceuticals, Opella, Mirum and Boehringer Ingelheim by way of unrestricted grants or sponsorships. None of the grantors or sponsors have had any influence over or input into the content provided by EASL on the EASL Campus platform, in order to preserve scientific integrity and independence